JP2021519764A5 - - Google Patents
Info
- Publication number
- JP2021519764A5 JP2021519764A5 JP2020552324A JP2020552324A JP2021519764A5 JP 2021519764 A5 JP2021519764 A5 JP 2021519764A5 JP 2020552324 A JP2020552324 A JP 2020552324A JP 2020552324 A JP2020552324 A JP 2020552324A JP 2021519764 A5 JP2021519764 A5 JP 2021519764A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- substituted
- membered
- nhc
- days
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862649428P | 2018-03-28 | 2018-03-28 | |
| US62/649,428 | 2018-03-28 | ||
| PCT/US2019/023917 WO2019190999A1 (en) | 2018-03-28 | 2019-03-25 | Method of treating fibrotic disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021519764A JP2021519764A (ja) | 2021-08-12 |
| JP2021519764A5 true JP2021519764A5 (https=) | 2022-03-31 |
| JPWO2019190999A5 JPWO2019190999A5 (https=) | 2022-03-31 |
Family
ID=68060720
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020552324A Pending JP2021519764A (ja) | 2018-03-28 | 2019-03-25 | 線維性疾患を処置する方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20210113560A1 (https=) |
| EP (1) | EP3774785A4 (https=) |
| JP (1) | JP2021519764A (https=) |
| KR (1) | KR20200139721A (https=) |
| CN (1) | CN112166111A (https=) |
| AU (1) | AU2019242595A1 (https=) |
| BR (1) | BR112020019325A2 (https=) |
| CA (1) | CA3093749A1 (https=) |
| CL (1) | CL2020002465A1 (https=) |
| IL (1) | IL277500A (https=) |
| MX (1) | MX2020010034A (https=) |
| RU (1) | RU2020130012A (https=) |
| SG (1) | SG11202008773PA (https=) |
| TW (1) | TW202003503A (https=) |
| WO (1) | WO2019190999A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3481835A4 (en) | 2016-07-05 | 2020-02-26 | Blade Therapeutics, Inc. | CALPAIN MODULATORS AND THERAPEUTIC USE THEREOF |
| BR112019006110A2 (pt) | 2016-09-28 | 2019-09-10 | Blade Therapeutics Inc | moduladores de calpaína e usos terapêuticos dos mesmos |
| CA3095164A1 (en) * | 2018-03-28 | 2019-10-03 | Blade Therapeutics, Inc. | Calpain modulators and therapeutic uses thereof |
| WO2020006294A1 (en) * | 2018-06-28 | 2020-01-02 | Blade Therapeutics, Inc. | Methods of treating liver fibrosis using calpain inhibitors |
| PH12022553378A1 (en) | 2020-06-10 | 2024-03-25 | Univ Leuven Kath | Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections |
| JP2024525589A (ja) | 2021-07-09 | 2024-07-12 | アリゴス セラピューティクス インコーポレイテッド | 抗ウイルス化合物 |
| WO2023043816A1 (en) | 2021-09-17 | 2023-03-23 | Aligos Therapeutics, Inc. | Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09500087A (ja) * | 1992-06-24 | 1997-01-07 | コーテックス ファーマシューティカルズ インコーポレイテッド | カルパイン活性の増大に関連した健康障害の抑制及び処置におけるカルパイン阻害剤の使用法 |
| DE69431718T2 (de) * | 1993-04-30 | 2003-07-10 | Merck & Co., Inc. | Thrombin-inhibitoren |
| AU5526098A (en) * | 1996-12-23 | 1998-07-17 | Biochem Pharma Inc. | Bicyclic thrombin inhibitors |
| ID22904A (id) * | 1997-05-02 | 1999-12-16 | Akzo Nobel Nv | Penghambat serin protease |
| DE19817459A1 (de) * | 1998-04-20 | 1999-10-21 | Basf Ag | Neue heterozyklische substituierte Amide, Herstellung und Anwendung |
| US20100094755A1 (en) * | 2008-10-09 | 2010-04-15 | Nelnet Business Solutions, Inc. | Providing payment data tokens for online transactions utilizing hosted inline frames |
| TWI519530B (zh) * | 2009-02-20 | 2016-02-01 | 艾伯維德國有限及兩合公司 | 羰醯胺化合物及其作為鈣蛋白酶（ｃａｌｐａｉｎ）抑制劑之用途 |
| WO2012076639A1 (en) * | 2010-12-09 | 2012-06-14 | Abbott Gmbh & Co. Kg | Carboxamide compounds and their use as calpain inhibitors v |
| JP2015512427A (ja) * | 2012-04-03 | 2015-04-27 | アッヴィ・ドイチュラント・ゲー・エム・ベー・ハー・ウント・コー・カー・ゲー | カルボキサミド化合物およびそれのカルパイン阻害薬ｖとしての使用 |
| CN104955801B (zh) * | 2012-11-30 | 2017-10-31 | 诺沃梅迪科斯有限公司 | 取代的二芳基磺酰胺及其用途 |
| CN105792831A (zh) * | 2013-10-08 | 2016-07-20 | 普罗麦迪奥股份有限公司 | 用于治疗纤维化癌症的方法 |
| BR112019006110A2 (pt) * | 2016-09-28 | 2019-09-10 | Blade Therapeutics Inc | moduladores de calpaína e usos terapêuticos dos mesmos |
| CA3095164A1 (en) * | 2018-03-28 | 2019-10-03 | Blade Therapeutics, Inc. | Calpain modulators and therapeutic uses thereof |
-
2019
- 2019-03-25 KR KR1020207030882A patent/KR20200139721A/ko not_active Ceased
- 2019-03-25 BR BR112020019325-9A patent/BR112020019325A2/pt not_active IP Right Cessation
- 2019-03-25 CN CN201980035685.4A patent/CN112166111A/zh active Pending
- 2019-03-25 JP JP2020552324A patent/JP2021519764A/ja active Pending
- 2019-03-25 MX MX2020010034A patent/MX2020010034A/es unknown
- 2019-03-25 WO PCT/US2019/023917 patent/WO2019190999A1/en not_active Ceased
- 2019-03-25 US US17/041,611 patent/US20210113560A1/en not_active Abandoned
- 2019-03-25 AU AU2019242595A patent/AU2019242595A1/en not_active Abandoned
- 2019-03-25 EP EP19777960.6A patent/EP3774785A4/en not_active Withdrawn
- 2019-03-25 RU RU2020130012A patent/RU2020130012A/ru unknown
- 2019-03-25 CA CA3093749A patent/CA3093749A1/en active Pending
- 2019-03-25 SG SG11202008773PA patent/SG11202008773PA/en unknown
- 2019-03-28 TW TW108111018A patent/TW202003503A/zh unknown
-
2020
- 2020-09-22 IL IL277500A patent/IL277500A/en unknown
- 2020-09-24 CL CL2020002465A patent/CL2020002465A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021519764A5 (https=) | ||
| ES3031577T3 (en) | Treatment of type 2 diabetes with 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl} piperidin-1-yl)methyl]-1-[(2s)-oxetan-2-ylmethyl]-1h-benzimidazole-6-carboxylic acid or a pharmaceutically salt thereof | |
| ES2507491T3 (es) | Preparación farmacéutica que comprende un inhibidor de DPP-IV y otros agentes terapéuticos de la diabetes en forma concomitante o combinada | |
| JP2021519312A5 (https=) | ||
| JP2009514874A5 (https=) | ||
| JP2006182786A5 (https=) | ||
| EA022040B1 (ru) | Применение бетанехола для лечения ксеростомии | |
| JP2008501753A5 (https=) | ||
| CN110169962B (zh) | 用于治疗癌症的氧烯洛尔组合物 | |
| RU2020130012A (ru) | Способ лечения фиброзного заболевания | |
| JP2021525787A5 (https=) | ||
| JP2002537258A5 (https=) | ||
| US20160184252A1 (en) | Compositions comprising 15-hepe and methods of treating or preventing fibrosis using same | |
| JP4011114B2 (ja) | 脳浮腫抑制剤 | |
| JP2025027020A (ja) | 患者において血清リン酸塩を低下させるための組み合わせ | |
| JPWO2019190999A5 (https=) | ||
| JP2004517808A5 (https=) | ||
| KR101174930B1 (ko) | ２-아미노-１,３-프로판디올 화합물의 화합물 제제 | |
| JP4824573B2 (ja) | 腎不全、腎疾患または腎障害、特に糖尿病患者におけるこれらの治療のための医薬組成物 | |
| JP2020040978A (ja) | サルコイドーシスを処置するための１，３−プロパンジスルホン酸またはその薬学的に許容される塩の使用 | |
| EP3010508B1 (en) | Combination of ro5503781, capecitabine and oxaliplatin for cancer therapy | |
| CN116421607A (zh) | 1,2,4三唑并4,3-b哒嗪衍生物在制备抗特发性肺纤维化药物中的应用 | |
| JPH08165236A (ja) | 下痢の予防及び治療剤 | |
| JP2020520904A5 (https=) | ||
| JP2005509634A5 (https=) |